Human neutralizing antibodies against MERS coronavirus: implications for future immunotherapy

Immunotherapy. 2015;7(6):591-4. doi: 10.2217/imt.15.33. Epub 2015 Jun 22.
No abstract available

Keywords: IGHV1–69; MERS-CoV; animal model; biodefense; emerging pathogen; human monoclonal antibodies; humoral immunity; passive immunotherapy; spike protein; zoonosis.

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Antibodies, Neutralizing / immunology
  • Antibodies, Neutralizing / therapeutic use*
  • Antibodies, Viral / immunology
  • Antibodies, Viral / therapeutic use*
  • Coronavirus Infections / immunology
  • Coronavirus Infections / therapy*
  • Humans
  • Immunotherapy*
  • Middle East Respiratory Syndrome Coronavirus / immunology*
  • Portraits as Topic

Substances

  • Antibodies, Neutralizing
  • Antibodies, Viral